San Diego, California and
Ludwigshafen, Germany
February 16, 2006
Diversa Corporation
(Nasdaq: DVSA) and BASF
(NYSE: BF) announced today that they have entered into a
broad alliance that will leverage Diversa's leadership
position in novel enzyme development and BASF's expertise in
biotechnology, process development, product applications,
and global marketing and distribution. Under the agreement,
Diversa will be responsible for discovery and optimization
of new enzymes, and BASF will be responsible for product and
process development and all commercialization matters.
The new agreement is a
significant expansion of the relationship between Diversa and
BASF that began in 2001 with a collaborative agreement to
develop biocatalysts. In 2003, under the original agreement,
BASF licensed a proprietary enzyme from Diversa for the
biocatalytic synthesis of a chiral pharmaceutical intermediate.
The two companies will be focusing on improving industrial
processes and product performance by combining BASF's
application know how, chemical and biotechnology expertise and
market knowledge with Diversa's enzyme discovery and
optimization technologies.
"Diversa and BASF intend to
leverage our combined expertise in biotechnology and chemistry
aiming at system innovations for diverse industrial
applications," said Dr. Alfred Hackenberger, BASF's President of
Specialty Chemicals Research. "We look forward to addressing
several exciting opportunities by developing better products to
help our customers in several key markets like pulp and paper or
fine chemicals to be more successful."
"Diversa has a well-established
track record of applying powerful and patented enzyme discovery
and optimization technologies to develop differentiated enzyme
products. With this broad new agreement, Diversa will become a
strategic partner in BASF's biotechnology activities and will
apply these technologies to assist BASF in extending its
well-deserved reputation as one of the industry leaders in the
development of innovative bio-based products," stated Edward T.
Shonsey, Diversa's Chief Executive Officer.
BASF has more than two decades
of experience in the area of biotechnology. The company uses
biocatalytic processes to produce a variety of products like
vitamin B2, the amino acid lysine, and chiral intermediates
(ChiPros(TM)) by means of living cell fermentation or enzyme
catalysis. In 2005, BASF posted sales of around Euro400 million
with products generated completely or partially using
biotechnological processes. Expanding research activities within
BASF's "Growth Cluster White Biotechnology" will be supported by
investments of 150 million euros over the period 2006 to 2008.
BASF is the world's leading
chemical company: The Chemical Company. Its portfolio ranges
from chemicals, plastics, performance products, agricultural
products and fine chemicals to crude oil and natural gas. As a
reliable partner to virtually all industries, BASF's intelligent
solutions and high-value products help its customers to be more
successful. BASF develops new technologies and uses them to open
up additional market opportunities. It combines economic success
with environmental protection and social responsibility, thus
contributing to a better future. In 2004, BASF had approximately
82,000 employees and posted sales of more than 37 billion euros.
BASF shares are traded on the stock exchanges in Frankfurt
(BAS), London (BFA), New York (BF) and Zurich (AN).
Diversa Corporation is a
leader in applying proprietary genomic technologies for the
rapid discovery and optimization of novel protein-based
products. Diversa is directing its integrated portfolio of
technologies to the discovery, evolution, and production of
commercially valuable molecules with agricultural, chemical,
industrial, and pharmaceutical applications. Diversa has
established alliances and joint ventures with market leaders,
such as BASF, Cargill Health and Food Technologies, DuPont
Bio-Based Materials, Medarex, Merck, and Xoma. In addition,
Diversa has formed a broad strategic relationship with Syngenta
AG, a world-leading agribusiness company. Diversa has
commercialized products both independently and in collaboration
with strategic partners and licensees. |